Removing organs "just in case" - Is prophylactic removal of the ovaries a good thing?

Journal of Epidemiology and Community Health

Volumn 60, Issue 3, 2006, Pages 186-187

  Clarke, Aileen ^a   Chang, Yu Mei ^a   McPherson, Klim ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE; ESTROGEN; HORMONE;

WOMENS HEALTH;

ADENOMYOSIS; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CARDIOVASCULAR DISEASE; EDITORIAL; ENDOMETRIOSIS; FRACTURE; GENETIC MARKER; HEALTH CARE POLICY; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MENOPAUSE; MENORRHAGIA; METRORRHAGIA; OVARIECTOMY; OVARY; OVARY CANCER; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; QUALITY OF LIFE; UNITED KINGDOM; UTERUS MYOMA; UTERUS PROLAPSE;

FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PUBLIC HEALTH;

EID: 33344468774     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2005.035170     Document Type: Editorial

References (27)

1. UK Department of Health. Hospital episode statistics 2003. http://www.dh.statistics/hes/.
2. Maresh MJ, Metcalfe MA, McPherson K, et al. The VALUE national hysterectomy study: description of the patients and their surgery. BJOG 2002;109:302-12.
3. Fignon A. Bilateral ovarian removal during hysterectomy: what is done and what should be done. Eur J Obstet Gynecol Reprod Biol 1998;76:201-5.
4. Vuorma S, Teperi J, Hurskainen R, et al. Hysterectomy trends in Finland in 1987-1995-a register based analysis. Acta Obstet Gynecol Scand 1998;77:770-6.
5. Progetta Menopausa Italic Study Group. Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy. Maturitas 2000;36:19-25.
6. Lewis CE, Groff JY, Herman O, et al. Overview of women's decision making regarding elective hysterectomy, oophorectomy, and hormone replacement therapy. J Womens Health Gend Based Med 2000;9(suppl 2):S5-14.
7. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute, http://seer.cancer. gov/CSR/1975_2002/ (based on Nov 2004 SEER data submission, posted to the SEER web site 2005.
8. Office for National Statistics. Cancer statistics registrations: registrations of cancer diagnosed in 2001. London: National Statistics, 2004.
9. Office for National Statistics. Mortality statistics: cause, England and Wales. London: National Statistics, 2005.
10. Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-15.
11. Esashi F, Christ N, Gannon J, et al. CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 2005;434:598-604.
12. Salom EM, Schey D, Penalver M, et al. The safety of incidental appendectomy at the time of abdominal hysterectomy. Am J Obstet Gynecol 2003;189:1563-7.
13. Mahdavi A, Berker B, Nezhat C, et al. Laparoscopic management of ovarian remnant. Obstet Gynecol Clin North Am 2004;31:593-7.
14. Pell I, Dowie J, Clarke A, et al. Development and preliminary evaluation of a clinical guidance programme for the prophylactic oophorectomy decision. Quality in Health Care 2002;11:32-9.
15. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:223-30.
16. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47:94-100.
17. Oldenhave A, Jaszmann LBJ, Everaard TAM, et al. Hysterectomised women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 1993;68:765-71.
18. Chiaffarino F, Parazzini F, Decarli A, et al. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer. Gynecol Oncol 2005;97:318-22.
19. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
20. Hsia J, Barad D, Margolis K, et al, for Women's Health Initiative Research Group. Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (The Women's Health Initiative). Am J Cardiol 2003;92:264-9.
21. Beral V. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the million women study. Lancet 2003;362:419-27.
22. Melton LJ 3rd, Khosla S, Malkasian GD, et al. racture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 2003;18:900-5.
23. Reid PC, Mukri F. Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3. BMJ 2005;330:938-9.
24. Chan LY, Yuen PM. Influence of the Women's Health Initiative trial on the practice of prophylactic oophorectomy and the prescription of estrogen therapy. (Letter). Fertil Steril 2004;81:1699-700.
25. Kuh D, Stirling S. Socioeconomic variation in admission for diseases of female genital system and breast in a national cohort aged 15-43. BMJ 1995;311:840-3.
26. Clarke A, Judge A, Herbert A, et al. Readmission to hospital 5 years after hysterectomy or endometrial resection in a national cohort study. Quality and Safety in Health care 2005;1:41-7.
27. Sizzi O, Paparella P, Bonito C, et al. Laparoscopic assistance after vaginal hysterectomy and unsuccessful access to the ovaries or failed uterine mobilization: changing trends. Journal of the Society of Laparoendoscopic Surgeons 2004;8:339-46.